Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?
- DOI
- 10.21037/hbsn-2025-587
- Published
- 2026-02
- Container
- Hepatobiliary Surgery and Nutrition
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/hbsn-2025-587,
title = {Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?},
author = {Faik G. Uzunoglu and Christoph Springfeld and Teresa Peccerella and Thomas Hank and Martin Loos and Christoph W. Michalski and Thilo Hackert and John P. Neoptolemos},
year = {2026},
journal = {Hepatobiliary Surgery and Nutrition},
doi = {10.21037/hbsn-2025-587},
url = {https://doi.org/10.21037/hbsn-2025-587}
}RIS
TY - JOUR TI - Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation? AU - Faik G. Uzunoglu AU - Christoph Springfeld AU - Teresa Peccerella AU - Thomas Hank AU - Martin Loos AU - Christoph W. Michalski AU - Thilo Hackert AU - John P. Neoptolemos PY - 2026 JO - Hepatobiliary Surgery and Nutrition DO - 10.21037/hbsn-2025-587 UR - https://doi.org/10.21037/hbsn-2025-587 ER -
APA
Uzunoglu, F. G., Springfeld, C., Peccerella, T., Hank, T., Loos, M., Michalski, C. W., Hackert, T., & Neoptolemos, J. P. (2026). Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?. Hepatobiliary Surgery and Nutrition. https://doi.org/10.21037/hbsn-2025-587
Source records
- crossref · retrieved 2026-09-27T01:31:13.245Z